11 February 2025
2025 marks the 10th anniversary of the International Day of Women and Girls in Science. We are incredibly proud to celebrate the remarkable women working at BioGeneric Pharma in Cairo, Egypt. These talented individuals make up 40% of the workforce, with over 70% holding Science degrees from Egyptian Universities. Their dedication and expertise are instrumental in the success of this state-of-the-art biopharmaceutical facility, which specialises in manufacturing therapeutic recombinant proteins and vaccines. Their contributions are vital to the mRNA Technology Transfer Programme and all the Partners. We honour and celebrate their commitment, achievements, and the significant impact they have on our industry and community.
More information about the mRNA Technology Transfer Programme: https://medicinespatentpool.org/what-we-do/mrna-technology-transfer-programme
Link on Youtube
Press and Media
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.
MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.